[1]Okada M. Regulation of the Src family kinases by Csk[J]. International Journal of Biological Sciences, 2012, 8(10):1385-1397. [2]Nada S, Okada M, Macauley A, et al. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src[J]. Nature, 1991, 351(6321):69-72. [3]Roskoski R. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors[J]. Pharmacological Research, 2015, 94:9-25. [4]Zheng R, Yano S, Matsumori Y, et al. Src inase nhibitor, M475271, uppresses ubcutaneous rowth and roduction of ung etastasis ia nhibition of roliferation, nvasion, and ascularization of uman ung denocarcinoma ells[J]. Clinical & Experimental Metastasis, 2005, 22(3):195-204. [5]Shin HK, Ryu BJ, Choi S, et al. Inactivation of rc-to-zrin athway:A ossible echanism in the uabain-ediated nhibition of A549 ell igration[J]. BioMed Research International, 2015, 2015:1-10. [6]Yang CC, Fazli L, Loguercio S, et al. Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass[J]. Oncotarget, 2015, 6(26):22060-22071. [7]Jeon BK, Kwon K, Kang JL, et al. Csk-nduced hosphorylation of rc at yrosine 530 is ssential for H2O2-ediated uppression of ERK1/2 in uman mbilical ein ndothelial ells[J]. Scientific Reports, 2015, 5:12725. [8]Hakam A, Fang Q, Karl R, et al. Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma[J]. Dig Dis Sci, 2003, 48(10):1972-1978. [9]Manz BN, Tan YX, Courtney AH, et al. Small molecule inhibition of Csk alters affinity recognition by T cells[J]. ELife, 2015, 4: doi:10. 7554/eLife. 08088. [10]Zhou D. Overexpression of Csk-binding protein decreases growth, invasion, and migration of esophageal carcinoma cells by controlling Src activation[J]. World Journal of Gastroenterology, 2015, 21(6):1814. [11]Arbet-Engels C, Tartare-Deckert S, Eckhart W. C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor[J]. J Biol Chem, 1999, 274(9):5422-5428. [12]Brehme M, Hantschel O, Colinge J, et al. Charting the molecular network of the drug target Bcr-Abl[J]. Proc Natl Acad Sci USA, 2009, 106(18):7414-7419. [13]Taliaferro-Smith L, Oberlick E, Liu T, et al. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells[J]. Oncotarget, 2015, 6(7):4757-4772. [14]Wollin L, Maillet I, Quesniaux V, et al. Antifibrotic and nti-inflammatory ctivity of the yrosine inase nhibitor intedanib in xperimental odels of ung ibrosis[J]. Journal of Pharmacology and Experimental Therapeutics, 2014, 349(2):209-220. [15]Huang K, Hu J, Li X, et al. Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor[J]. Drug Metab Pharmacokinet, 2012, 27(5):486-494. [16]瞿紫微, 王晓燕, 魏欣, 等. SRC激酶抑制剂对前列腺癌细胞侵袭与增殖的影响[J]. 现代肿瘤医学, 2011(11):2178-2180. [17]Oneyama C, Hikita T, Enya K, et al. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src[J]. Mol Cell, 2008, 30(4):426-436. [18]Nakagawa T, Tanaka S, Suzuki H, et al. Overexpression of the csk gene suppresses tumor metastasis in vivo[J]. Int J Cancer, 2000, 88(3):384-391. [19]Sabe H, Knudsen B, Okada M, et al. Molecular cloning and expression of chicken C-terminal Src kinase:lack of stable association with c-Src protein[J]. Proc Natl Acad Sci USA, 1992, 89(6):2190-2194. [20]Thomas RM, Schmedt C, Novelli M, et al. C-terminal SRC kinase controls acute inflammation and granulocyte adhesion[J]. Immunity, 2004, 20(2):181-191. [21]Yagi R, Waguri S, Sumikawa Y, et al. C-terminal Src kinase controls development and maintenance of mouse squamous epithelia[J]. Embo J, 2007, 26(5):1234-1244. [22]Nada S, Okada M, Aizawa S, et al. Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells[J]. Oncogene, 1994, 9(12):3571-3578. [23]Jamros MA, Oliveira LC, Whitford PC, et al. Substrate-specific reorganization of the conformational ensemble of CSK implicates novel modes of kinase function[J]. PLoS Comput Biol, 2012, 8(9):e1002695. [24]Place AT, Chen Z, Bakhshi FR, et al. Cooperative ole of Caveolin-1 and C-erminal Src inase inding rotein in C-erminal Src inase-ediated egative egulation of c-Src[J]. Molecular Pharmacology, 2011, 80(4):665-672.
|